- Home
- Publications
- Publication Search
- Publication Details
Title
WBSCR22 confers oxaliplatin resistance in human colorectal cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-07
DOI
10.1038/s41598-017-15749-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-Wide Study of Hypomethylated and Induced Genes in Patients with Liver Cancer Unravels Novel Anticancer Targets
- (2014) B. Stefanska et al. CLINICAL CANCER RESEARCH
- Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
- (2014) Christian Rolfo et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The Methyltransferase WBSCR22/Merm1 Enhances Glucocorticoid Receptor Function and Is Regulated in Lung Inflammation and Cancer
- (2014) Maryam Jangani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levels
- (2014) DONGMEI YAN et al. Molecular Medicine Reports
- Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells
- (2014) Sayo Suzuki et al. Proteome Science
- Friend or foe: the role of microRNA in chemotherapy resistance
- (2013) Haoran Li et al. ACTA PHARMACOLOGICA SINICA
- Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer
- (2013) Z.-l. Zeng et al. CLINICAL CANCER RESEARCH
- XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection
- (2013) Stephanie B. Hatch et al. INTERNATIONAL JOURNAL OF CANCER
- miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase
- (2013) Yunfei Zhou et al. Molecular Oncology
- The Human WBSCR22 Protein Is Involved in the Biogenesis of the 40S Ribosomal Subunits in Mammalian Cells
- (2013) Kadri Õunap et al. PLoS One
- Genomics and Cancer Drug Resistance
- (2012) Antonio S. Rodrigues et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
- (2012) Yu-Lin Lin et al. PLoS One
- Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome
- (2011) R. E. Tiedemann et al. CANCER RESEARCH
- The Novel Metastasis Promoter Merm1/Wbscr22 Enhances Tumor Cell Survival in the Vasculature by Suppressing Zac1/p53-Dependent Apoptosis
- (2010) Y. Nakazawa et al. CANCER RESEARCH
- Uncovering the Human Methyltransferasome
- (2010) Tanya C. Petrossian et al. MOLECULAR & CELLULAR PROTEOMICS
- Williams–Beuren Syndrome
- (2010) Barbara R. Pober NEW ENGLAND JOURNAL OF MEDICINE
- Base excision repair of reactive oxygen species-initiated 7,8-dihydro-8-oxo-2'-deoxyguanosine inhibits the cytotoxicity of platinum anticancer drugs
- (2009) T. J. Preston et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment
- (2008) Meghan B. Azad et al. ANTIOXIDANTS & REDOX SIGNALING
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started